@lama-awada.bsky.social
Reposted
Rounding out the session is Tom Le Voyer from Institut Imagine.
He is discussing "NF-kB, Thymus and autoimmunity", exploring the critical signaling pathways that prevent our immune system from turning against itself. 📉🦠
That wraps up this week's talks! See you next week! 👏
He is discussing "NF-kB, Thymus and autoimmunity", exploring the critical signaling pathways that prevent our immune system from turning against itself. 📉🦠
That wraps up this week's talks! See you next week! 👏
February 12, 2026 at 12:36 PM
Rounding out the session is Tom Le Voyer from Institut Imagine.
He is discussing "NF-kB, Thymus and autoimmunity", exploring the critical signaling pathways that prevent our immune system from turning against itself. 📉🦠
That wraps up this week's talks! See you next week! 👏
He is discussing "NF-kB, Thymus and autoimmunity", exploring the critical signaling pathways that prevent our immune system from turning against itself. 📉🦠
That wraps up this week's talks! See you next week! 👏
Reposted
Next on stage is Gonçalo Nogueira from @pasteur.fr
His talk, "Embryonic thymocyte-epithelial cell interaction plays an essential role in the establishment of adult T cell tolerance," highlights how early development shapes our immune system's future in the context of the thymus. 🧬🛡️
His talk, "Embryonic thymocyte-epithelial cell interaction plays an essential role in the establishment of adult T cell tolerance," highlights how early development shapes our immune system's future in the context of the thymus. 🧬🛡️
February 12, 2026 at 12:29 PM
Next on stage is Gonçalo Nogueira from @pasteur.fr
His talk, "Embryonic thymocyte-epithelial cell interaction plays an essential role in the establishment of adult T cell tolerance," highlights how early development shapes our immune system's future in the context of the thymus. 🧬🛡️
His talk, "Embryonic thymocyte-epithelial cell interaction plays an essential role in the establishment of adult T cell tolerance," highlights how early development shapes our immune system's future in the context of the thymus. 🧬🛡️
Reposted
Now, a more detailed look at the ATO system within T-ALL! 🔍
Valentine Louis (INEM) and Clarisse Godard (Institut Saint-Louis) are presenting "Modeling human leukemia using a 3D ATO (Artificial Thymic Organoid) system."
Valentine Louis (INEM) and Clarisse Godard (Institut Saint-Louis) are presenting "Modeling human leukemia using a 3D ATO (Artificial Thymic Organoid) system."
February 12, 2026 at 12:19 PM
Now, a more detailed look at the ATO system within T-ALL! 🔍
Valentine Louis (INEM) and Clarisse Godard (Institut Saint-Louis) are presenting "Modeling human leukemia using a 3D ATO (Artificial Thymic Organoid) system."
Valentine Louis (INEM) and Clarisse Godard (Institut Saint-Louis) are presenting "Modeling human leukemia using a 3D ATO (Artificial Thymic Organoid) system."
Reposted
🧪 We are kicking off this week’s MAGIC meeting! First up is @guillaumeandrieu.bsky.social from @inem-necker.bsky.social (Normal & Pathological Lymphoid Differentiation Lab).
He is presenting "Leukemia on ChIP: application," diving into new methodologies for understanding leukemia. 🔬 🧵👇
He is presenting "Leukemia on ChIP: application," diving into new methodologies for understanding leukemia. 🔬 🧵👇
February 12, 2026 at 12:11 PM
🧪 We are kicking off this week’s MAGIC meeting! First up is @guillaumeandrieu.bsky.social from @inem-necker.bsky.social (Normal & Pathological Lymphoid Differentiation Lab).
He is presenting "Leukemia on ChIP: application," diving into new methodologies for understanding leukemia. 🔬 🧵👇
He is presenting "Leukemia on ChIP: application," diving into new methodologies for understanding leukemia. 🔬 🧵👇
Reposted
Happening now at Institut Imagine! 🏛️✨
Prof. Anna Kajaste-Rudnitski (Univ. of Pavia) is on stage dissecting the "double-edged sword" of innate immunity. ⚔️🧬
She is explaining how the same mechanisms that protect us from viruses can block gene therapies and drive CNS inflammation.
Prof. Anna Kajaste-Rudnitski (Univ. of Pavia) is on stage dissecting the "double-edged sword" of innate immunity. ⚔️🧬
She is explaining how the same mechanisms that protect us from viruses can block gene therapies and drive CNS inflammation.
February 9, 2026 at 12:24 PM
Happening now at Institut Imagine! 🏛️✨
Prof. Anna Kajaste-Rudnitski (Univ. of Pavia) is on stage dissecting the "double-edged sword" of innate immunity. ⚔️🧬
She is explaining how the same mechanisms that protect us from viruses can block gene therapies and drive CNS inflammation.
Prof. Anna Kajaste-Rudnitski (Univ. of Pavia) is on stage dissecting the "double-edged sword" of innate immunity. ⚔️🧬
She is explaining how the same mechanisms that protect us from viruses can block gene therapies and drive CNS inflammation.
Reposted
Wrapping up with Emmanuelle Six on Gene Therapy. 🧬
Chronic inflammation "exhausts" our blood stem cells (HSPCs), making them less fit for genetic engineering. Emmanuelle is sharing solutions to protect stem cell fitness, ensuring that life-saving gene therapies work better and last longer. 🧪
Chronic inflammation "exhausts" our blood stem cells (HSPCs), making them less fit for genetic engineering. Emmanuelle is sharing solutions to protect stem cell fitness, ensuring that life-saving gene therapies work better and last longer. 🧪
February 5, 2026 at 12:39 PM
Wrapping up with Emmanuelle Six on Gene Therapy. 🧬
Chronic inflammation "exhausts" our blood stem cells (HSPCs), making them less fit for genetic engineering. Emmanuelle is sharing solutions to protect stem cell fitness, ensuring that life-saving gene therapies work better and last longer. 🧪
Chronic inflammation "exhausts" our blood stem cells (HSPCs), making them less fit for genetic engineering. Emmanuelle is sharing solutions to protect stem cell fitness, ensuring that life-saving gene therapies work better and last longer. 🧪
Reposted
Thiago Trovati is discussing a creative approach to Sickle Cell Disease (SCD): drug repurposing. 🔄
Focusing on Acute Chest Syndrome (a life-threatening complication), he’s exploring how drugs like tocilizumab, might help SCD patients by addressing ineffective erythropoiesis.🩸 #Hematology #SCD
Focusing on Acute Chest Syndrome (a life-threatening complication), he’s exploring how drugs like tocilizumab, might help SCD patients by addressing ineffective erythropoiesis.🩸 #Hematology #SCD
February 5, 2026 at 12:34 PM
Thiago Trovati is discussing a creative approach to Sickle Cell Disease (SCD): drug repurposing. 🔄
Focusing on Acute Chest Syndrome (a life-threatening complication), he’s exploring how drugs like tocilizumab, might help SCD patients by addressing ineffective erythropoiesis.🩸 #Hematology #SCD
Focusing on Acute Chest Syndrome (a life-threatening complication), he’s exploring how drugs like tocilizumab, might help SCD patients by addressing ineffective erythropoiesis.🩸 #Hematology #SCD
Reposted
Deep dive into the gut with David Skurnik (INEM). He has identified Oxalyl-CoA decarboxylase as a critical "survival tool" for Adherent Invasive E. coli (AIEC) in the harsh, acidic environment of the inflamed gut. 🦠
February 5, 2026 at 12:32 PM
Deep dive into the gut with David Skurnik (INEM). He has identified Oxalyl-CoA decarboxylase as a critical "survival tool" for Adherent Invasive E. coli (AIEC) in the harsh, acidic environment of the inflamed gut. 🦠
Reposted
Next, Marie Louise Frémond talking about interferonopathies. These rare genetic disorders are driven by an "overdose" of type I interferon.
She's highlighting the efficacy of Anifrolumab—an IFNAR1 receptor blocker. Results show a significant "normalization" of the interferon signature in patients. 💊
She's highlighting the efficacy of Anifrolumab—an IFNAR1 receptor blocker. Results show a significant "normalization" of the interferon signature in patients. 💊
February 5, 2026 at 12:12 PM
Next, Marie Louise Frémond talking about interferonopathies. These rare genetic disorders are driven by an "overdose" of type I interferon.
She's highlighting the efficacy of Anifrolumab—an IFNAR1 receptor blocker. Results show a significant "normalization" of the interferon signature in patients. 💊
She's highlighting the efficacy of Anifrolumab—an IFNAR1 receptor blocker. Results show a significant "normalization" of the interferon signature in patients. 💊
Reposted
📢 Kicking off today’s MAGIC meeting: Jean-François Gautier (Lariboisière) is discussing the shift in how we view Type 2 Diabetes, not just as a metabolic disorder, but as a chronic inflammatory disease. 🧬
February 5, 2026 at 12:04 PM
📢 Kicking off today’s MAGIC meeting: Jean-François Gautier (Lariboisière) is discussing the shift in how we view Type 2 Diabetes, not just as a metabolic disorder, but as a chronic inflammatory disease. 🧬
Reposted
🧬 Advancing Research in Paris with the Region's First AVITI24™ (Element Biosciences) !
We are thrilled to announce that Institut Imagine has officially acquired the first AVITI24 system in Paris.
We are thrilled to announce that Institut Imagine has officially acquired the first AVITI24 system in Paris.
February 2, 2026 at 4:30 PM
🧬 Advancing Research in Paris with the Region's First AVITI24™ (Element Biosciences) !
We are thrilled to announce that Institut Imagine has officially acquired the first AVITI24 system in Paris.
We are thrilled to announce that Institut Imagine has officially acquired the first AVITI24 system in Paris.
Reposted
🔬 Que se passe-t-il vraiment derrière une découverte scientifique ?
Le vendredi 6 mars 2026, l’Institut Imagine vous invite à participer à une rencontre d'une demi-journée sur le thème : « Qu’est-ce que la Recherche à l’Institut Imagine ? »
📌 Inscriptions : yji1wvqwixz.typeform.com/to/spGbo2dC
Le vendredi 6 mars 2026, l’Institut Imagine vous invite à participer à une rencontre d'une demi-journée sur le thème : « Qu’est-ce que la Recherche à l’Institut Imagine ? »
📌 Inscriptions : yji1wvqwixz.typeform.com/to/spGbo2dC
January 27, 2026 at 8:19 AM
🔬 Que se passe-t-il vraiment derrière une découverte scientifique ?
Le vendredi 6 mars 2026, l’Institut Imagine vous invite à participer à une rencontre d'une demi-journée sur le thème : « Qu’est-ce que la Recherche à l’Institut Imagine ? »
📌 Inscriptions : yji1wvqwixz.typeform.com/to/spGbo2dC
Le vendredi 6 mars 2026, l’Institut Imagine vous invite à participer à une rencontre d'une demi-journée sur le thème : « Qu’est-ce que la Recherche à l’Institut Imagine ? »
📌 Inscriptions : yji1wvqwixz.typeform.com/to/spGbo2dC
Reposted
Live at our weekly seminar: Prof. Chantal Pichon (Univ. Orléans) on the design of imidazolium lipid-based LNPs for mRNA delivery. 🧬
These LNPs use pH-responsive headgroups to improve cytosolic release for cancer vaccines & immune cell engineering. The future of nanomedicine! 🧪🎯 #mRNA #LNP
These LNPs use pH-responsive headgroups to improve cytosolic release for cancer vaccines & immune cell engineering. The future of nanomedicine! 🧪🎯 #mRNA #LNP
February 2, 2026 at 12:36 PM
Reposted
1/ We are excited to share our new report in PNAS: all three cases of encephalitis triggered by the live-attenuated chikungunya (CHIKV) vaccine (IXCHIQ®) are due to pre-existing autoantibodies neutralizing type I IFN (AAN-I-IFN) (doi.org/10.1073/pnas...).
January 26, 2026 at 9:30 PM
1/ We are excited to share our new report in PNAS: all three cases of encephalitis triggered by the live-attenuated chikungunya (CHIKV) vaccine (IXCHIQ®) are due to pre-existing autoantibodies neutralizing type I IFN (AAN-I-IFN) (doi.org/10.1073/pnas...).
Reposted
Closing today's session is Amine Toubal (INEM).
He is decoding the immunometabolic pathways that govern wound healing in Type 2 diabetes. Crucial work for understanding complications in metabolic disorders. 🩹🍬
That’s a wrap for this week’s meeting! See you all next week for more science!
He is decoding the immunometabolic pathways that govern wound healing in Type 2 diabetes. Crucial work for understanding complications in metabolic disorders. 🩹🍬
That’s a wrap for this week’s meeting! See you all next week for more science!
January 22, 2026 at 12:48 PM
Closing today's session is Amine Toubal (INEM).
He is decoding the immunometabolic pathways that govern wound healing in Type 2 diabetes. Crucial work for understanding complications in metabolic disorders. 🩹🍬
That’s a wrap for this week’s meeting! See you all next week for more science!
He is decoding the immunometabolic pathways that govern wound healing in Type 2 diabetes. Crucial work for understanding complications in metabolic disorders. 🩹🍬
That’s a wrap for this week’s meeting! See you all next week for more science!
Reposted
Next, we are looking at the lungs with Mairead Aubert (INEM). 🫁
Her talk focuses on the "Metabolic Control of Airway Epithelial Repair," specifically in the context of Cystic Fibrosis and beyond. Understanding repair mechanisms is key! 🌬️
Her talk focuses on the "Metabolic Control of Airway Epithelial Repair," specifically in the context of Cystic Fibrosis and beyond. Understanding repair mechanisms is key! 🌬️
January 22, 2026 at 12:36 PM
Next, we are looking at the lungs with Mairead Aubert (INEM). 🫁
Her talk focuses on the "Metabolic Control of Airway Epithelial Repair," specifically in the context of Cystic Fibrosis and beyond. Understanding repair mechanisms is key! 🌬️
Her talk focuses on the "Metabolic Control of Airway Epithelial Repair," specifically in the context of Cystic Fibrosis and beyond. Understanding repair mechanisms is key! 🌬️
Reposted
Welcoming Lucie Peduto from @pasteur.fr! 🏛️
She is diving into the role of stromal lineages in tissue homeostasis and disease. A fascinating look at the structural support systems of our biology.
#biology #research
She is diving into the role of stromal lineages in tissue homeostasis and disease. A fascinating look at the structural support systems of our biology.
#biology #research
January 22, 2026 at 12:23 PM
Welcoming Lucie Peduto from @pasteur.fr! 🏛️
She is diving into the role of stromal lineages in tissue homeostasis and disease. A fascinating look at the structural support systems of our biology.
#biology #research
She is diving into the role of stromal lineages in tissue homeostasis and disease. A fascinating look at the structural support systems of our biology.
#biology #research
Reposted
We are live for our weekly scientific meeting! 🧪
First up, Pierre Isnard from @inem-necker.bsky.social is presenting on HNF1B.
He is discussing how this factor integrates signals that drive failed repair and the progression of kidney disease. Critical insights into renal pathophysiology. 🩺
First up, Pierre Isnard from @inem-necker.bsky.social is presenting on HNF1B.
He is discussing how this factor integrates signals that drive failed repair and the progression of kidney disease. Critical insights into renal pathophysiology. 🩺
January 22, 2026 at 12:15 PM
We are live for our weekly scientific meeting! 🧪
First up, Pierre Isnard from @inem-necker.bsky.social is presenting on HNF1B.
He is discussing how this factor integrates signals that drive failed repair and the progression of kidney disease. Critical insights into renal pathophysiology. 🩺
First up, Pierre Isnard from @inem-necker.bsky.social is presenting on HNF1B.
He is discussing how this factor integrates signals that drive failed repair and the progression of kidney disease. Critical insights into renal pathophysiology. 🩺
Reposted
En 2026, continuons à faire avancer une recherche qui change des vies.
En ce début d’année, je vous adresse mes vœux les plus sincères. Merci à toutes celles et ceux qui nous soutiennent et nous font confiance.
Voir la vidéo : youtu.be/dVpBP92F2FI
En ce début d’année, je vous adresse mes vœux les plus sincères. Merci à toutes celles et ceux qui nous soutiennent et nous font confiance.
Voir la vidéo : youtu.be/dVpBP92F2FI
Voeux de la Pr Bana Jabri, Directrice générale de l'Institut Imagine
YouTube video by Institut Imagine
youtu.be
January 19, 2026 at 4:28 PM
En 2026, continuons à faire avancer une recherche qui change des vies.
En ce début d’année, je vous adresse mes vœux les plus sincères. Merci à toutes celles et ceux qui nous soutiennent et nous font confiance.
Voir la vidéo : youtu.be/dVpBP92F2FI
En ce début d’année, je vous adresse mes vœux les plus sincères. Merci à toutes celles et ceux qui nous soutiennent et nous font confiance.
Voir la vidéo : youtu.be/dVpBP92F2FI
Reposted
🦠 Closing our session is @manusingh.bsky.social discussing the "Long Shadow of Viral Infections".
He's showing how HIV & EBV can reactivate persistent, ancient Endogenous Retroviral proteins. A powerful reminder that our genome's history still dictates our health today!🧬
He's showing how HIV & EBV can reactivate persistent, ancient Endogenous Retroviral proteins. A powerful reminder that our genome's history still dictates our health today!🧬
January 15, 2026 at 1:04 PM
🦠 Closing our session is @manusingh.bsky.social discussing the "Long Shadow of Viral Infections".
He's showing how HIV & EBV can reactivate persistent, ancient Endogenous Retroviral proteins. A powerful reminder that our genome's history still dictates our health today!🧬
He's showing how HIV & EBV can reactivate persistent, ancient Endogenous Retroviral proteins. A powerful reminder that our genome's history still dictates our health today!🧬
Reposted
Moving to autoimmunity with Anaïs Levescot 🛡️
Her talk focuses on somatic clonal evolution of tissue-resident lymphocytes in chronic autoimmunity. Takeaway: Chronic activation isn't just inflammation, it's a pathogenic continuum where somatic mutations drive tissue damage and treatment resistance. 🧬
Her talk focuses on somatic clonal evolution of tissue-resident lymphocytes in chronic autoimmunity. Takeaway: Chronic activation isn't just inflammation, it's a pathogenic continuum where somatic mutations drive tissue damage and treatment resistance. 🧬
January 15, 2026 at 12:27 PM
Moving to autoimmunity with Anaïs Levescot 🛡️
Her talk focuses on somatic clonal evolution of tissue-resident lymphocytes in chronic autoimmunity. Takeaway: Chronic activation isn't just inflammation, it's a pathogenic continuum where somatic mutations drive tissue damage and treatment resistance. 🧬
Her talk focuses on somatic clonal evolution of tissue-resident lymphocytes in chronic autoimmunity. Takeaway: Chronic activation isn't just inflammation, it's a pathogenic continuum where somatic mutations drive tissue damage and treatment resistance. 🧬
Reposted
Next, Katrina Podsypanina (B. Manoury Lab, @inem-necker.bsky.social ) takes the stage to discuss a fascinating evolutionary link. She is exploring how Ancient Endogenous Retroviruses might be the missing link between maternal tolerance and how tumors evade the immune system. 🤰🧪
January 15, 2026 at 12:21 PM
Next, Katrina Podsypanina (B. Manoury Lab, @inem-necker.bsky.social ) takes the stage to discuss a fascinating evolutionary link. She is exploring how Ancient Endogenous Retroviruses might be the missing link between maternal tolerance and how tumors evade the immune system. 🤰🧪
Reposted
📢 We are live for our weekly scientific meeting! First up is Fabian Zanchetta (O. Hermine Lab) tackling "Unexplained Erythrocytosis." 🩸
Using the Dr. Warehouse clinical database, they are identifying new genetic drivers for patients with high red blood cell counts. 📉🔍
Using the Dr. Warehouse clinical database, they are identifying new genetic drivers for patients with high red blood cell counts. 📉🔍
January 15, 2026 at 12:09 PM
📢 We are live for our weekly scientific meeting! First up is Fabian Zanchetta (O. Hermine Lab) tackling "Unexplained Erythrocytosis." 🩸
Using the Dr. Warehouse clinical database, they are identifying new genetic drivers for patients with high red blood cell counts. 📉🔍
Using the Dr. Warehouse clinical database, they are identifying new genetic drivers for patients with high red blood cell counts. 📉🔍
Reposted
Pour la Pr Bana Jabri, investir dans la science est un choix essentiel pour notre santé et notre économie.
📖 Retrouvez l'entretien complet dans Le Figaro : sante.lefigaro.fr/medecine/pr-...
📖 Retrouvez l'entretien complet dans Le Figaro : sante.lefigaro.fr/medecine/pr-...
January 13, 2026 at 3:23 PM
Pour la Pr Bana Jabri, investir dans la science est un choix essentiel pour notre santé et notre économie.
📖 Retrouvez l'entretien complet dans Le Figaro : sante.lefigaro.fr/medecine/pr-...
📖 Retrouvez l'entretien complet dans Le Figaro : sante.lefigaro.fr/medecine/pr-...